| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ABCC1 ATP7A ABCC11 DHX57 CCT4 IDE CLPX KIF7 ABCB4 DDX46 KIF3B ABCB9 DDX53 ABCC2 HSPA5 VCP | 2.20e-07 | 441 | 169 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 3.38e-07 | 8 | 169 | 4 | GO:0015431 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 9.99e-07 | 10 | 169 | 4 | GO:0043225 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 ABCC1 ATP7A DRG2 ABCC11 DHX57 CCT4 IDE CLPX GTPBP10 RAB44 TRIM23 KIF7 ABCB4 DDX46 KIF3B ABCB9 NUDT1 DDX53 ABCC2 HSPA5 VCP | 2.50e-06 | 839 | 169 | 22 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 ABCC1 ATP7A DRG2 ABCC11 DHX57 CCT4 IDE CLPX GTPBP10 RAB44 TRIM23 KIF7 ABCB4 DDX46 KIF3B ABCB9 NUDT1 DDX53 ABCC2 HSPA5 VCP | 2.55e-06 | 840 | 169 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 ABCC1 ATP7A DRG2 ABCC11 DHX57 CCT4 IDE CLPX GTPBP10 RAB44 TRIM23 KIF7 ABCB4 DDX46 KIF3B ABCB9 NUDT1 DDX53 ABCC2 HSPA5 VCP | 2.55e-06 | 840 | 169 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 ABCC1 ATP7A DRG2 ABCC11 DHX57 CCT4 IDE CLPX GTPBP10 RAB44 TRIM23 KIF7 ABCB4 DDX46 KIF3B ABCB9 DDX53 ABCC2 HSPA5 VCP | 2.60e-06 | 775 | 169 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.48e-06 | 49 | 169 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCC1 ATP7A ABCC11 DHX57 CCT4 IDE CLPX KIF7 ABCB4 DDX46 KIF3B ABCB9 DDX53 ABCC2 HSPA5 ACSL5 VCP | 4.86e-06 | 614 | 169 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 6.28e-06 | 15 | 169 | 4 | GO:0008559 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 9.34e-06 | 34 | 169 | 5 | GO:0042910 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.97e-05 | 109 | 169 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 4.82e-05 | 9 | 169 | 3 | GO:0034040 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.66e-04 | 61 | 169 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 3.08e-04 | 16 | 169 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.91e-04 | 207 | 169 | 8 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.04e-04 | 208 | 169 | 8 | GO:0005342 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 4.23e-04 | 4 | 169 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 4.31e-04 | 42 | 169 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | ubiquitin-modified protein reader activity | 6.11e-04 | 20 | 169 | 3 | GO:0140036 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 6.11e-04 | 20 | 169 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 6.12e-04 | 46 | 169 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 8.16e-04 | 178 | 169 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 8.42e-04 | 50 | 169 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC3 ABCC1 SLC4A8 ABCC11 SLC38A10 SLC15A4 SLC16A14 SLC47A1 ABCC2 | 9.01e-04 | 293 | 169 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.05e-03 | 53 | 169 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein reader activity | 1.19e-03 | 25 | 169 | 3 | GO:0140035 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 2.47e-03 | 9 | 169 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC3 ABCC1 ATP7A SLC4A8 ABCC11 ABCB4 ABCB9 SLC15A4 SLC16A14 SLC47A1 ABCC2 | 2.53e-03 | 477 | 169 | 11 | GO:0022804 |
| GeneOntologyBiologicalProcess | leukotriene transport | 1.26e-07 | 7 | 162 | 4 | GO:0071716 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.10e-05 | 64 | 162 | 6 | GO:0042908 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 1.30e-05 | 19 | 162 | 4 | GO:0006855 | |
| GeneOntologyBiologicalProcess | protein folding | 2.57e-05 | 246 | 162 | 10 | GO:0006457 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.86e-05 | 9 | 162 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 5.48e-05 | 10 | 162 | 3 | GO:1903301 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.77e-05 | 8 | 168 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 5.87e-05 | 10 | 168 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.74e-04 | 14 | 168 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.81e-04 | 18 | 168 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 5.26e-04 | 20 | 168 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 6.10e-04 | 21 | 168 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | collagen trimer | 7.23e-04 | 88 | 168 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | focal adhesion | HSPG2 FLNB LCP1 ABCB4 NRP1 AHNAK CSPG4 MAP2K2 ENG HSPA5 SNTB2 | 7.53e-04 | 431 | 168 | 11 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | HSPG2 FLNB LCP1 ABCB4 NRP1 AHNAK CSPG4 MAP2K2 ENG HSPA5 SNTB2 | 9.41e-04 | 443 | 168 | 11 | GO:0030055 |
| Domain | ABC_membrane | 4.94e-08 | 24 | 164 | 6 | PF00664 | |
| Domain | ABC_TM1F | 1.34e-07 | 28 | 164 | 6 | PS50929 | |
| Domain | ABC1_TM_dom | 1.34e-07 | 28 | 164 | 6 | IPR011527 | |
| Domain | ABC_transporter_CS | 1.69e-06 | 42 | 164 | 6 | IPR017871 | |
| Domain | Multidrug-R_assoc | 2.64e-06 | 4 | 164 | 3 | IPR005292 | |
| Domain | ABC_tran | 3.78e-06 | 48 | 164 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.78e-06 | 48 | 164 | 6 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.28e-06 | 49 | 164 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 4.83e-06 | 50 | 164 | 6 | IPR003439 | |
| Domain | PDZ | 3.51e-05 | 141 | 164 | 8 | PF00595 | |
| Domain | AAA | 4.08e-05 | 144 | 164 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 4.08e-05 | 144 | 164 | 8 | IPR003593 | |
| Domain | PDZ | 4.95e-05 | 148 | 164 | 8 | SM00228 | |
| Domain | - | 5.45e-05 | 150 | 164 | 8 | 2.30.42.10 | |
| Domain | PDZ | 5.71e-05 | 151 | 164 | 8 | PS50106 | |
| Domain | PDZ | 5.98e-05 | 152 | 164 | 8 | IPR001478 | |
| Domain | Arp1 | 7.66e-05 | 2 | 164 | 2 | IPR029909 | |
| Domain | Ran_BP1 | 1.38e-04 | 12 | 164 | 3 | PF00638 | |
| Domain | RANBD1 | 1.38e-04 | 12 | 164 | 3 | PS50196 | |
| Domain | Laminin_G | 1.55e-04 | 58 | 164 | 5 | IPR001791 | |
| Domain | P-loop_NTPase | ABCC3 ABCC1 DRG2 ABCC11 DHX57 CLPX GTPBP10 TRIM23 SBNO2 KIF7 ABCB4 DDX46 KIF3B ABCB9 DYNC2LI1 DLG3 DDX53 ABCC2 VCP | 1.69e-04 | 848 | 164 | 19 | IPR027417 |
| Domain | RanBD | 1.78e-04 | 13 | 164 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.78e-04 | 13 | 164 | 3 | IPR000156 | |
| Domain | - | ABCC3 ABCC1 DRG2 ABCC11 DHX57 CLPX GTPBP10 TRIM23 SBNO2 ABCB4 DDX46 ABCB9 DYNC2LI1 DLG3 DDX53 ABCC2 VCP | 3.11e-04 | 746 | 164 | 17 | 3.40.50.300 |
| Domain | Laminin_G_2 | 4.09e-04 | 40 | 164 | 4 | PF02210 | |
| Domain | Actin/actin-like_CS | 4.92e-04 | 18 | 164 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.81e-04 | 19 | 164 | 3 | PS01132 | |
| Domain | Collagen | 9.15e-04 | 85 | 164 | 5 | IPR008160 | |
| Domain | Collagen | 9.15e-04 | 85 | 164 | 5 | PF01391 | |
| Domain | TSPN | 1.03e-03 | 23 | 164 | 3 | SM00210 | |
| Domain | Alpha_kinase | 1.12e-03 | 6 | 164 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 1.12e-03 | 6 | 164 | 2 | IPR004166 | |
| Domain | G_OBG | 1.12e-03 | 6 | 164 | 2 | IPR031167 | |
| Domain | ALPHA_KINASE | 1.12e-03 | 6 | 164 | 2 | PS51158 | |
| Domain | Alpha_kinase | 1.12e-03 | 6 | 164 | 2 | SM00811 | |
| Domain | G_OBG | 1.12e-03 | 6 | 164 | 2 | PS51710 | |
| Domain | Rab_bind | 1.56e-03 | 7 | 164 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.56e-03 | 7 | 164 | 2 | IPR032023 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.91e-06 | 44 | 121 | 6 | M11911 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 1.21e-05 | 6 | 121 | 3 | M22078 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.89e-05 | 103 | 121 | 7 | M758 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 HSPG2 KHNYN GBX2 ATG2A ZZEF1 SBNO2 CABLES1 MAPK8IP3 CDR2L ACTR1A SLC38A10 RPAP1 ZNF827 PIK3CD AHNAK TMCC2 CSPG4 TANC1 LTK ANKRD33B PICK1 AHNAK2 | 5.40e-09 | 1105 | 170 | 23 | 35748872 |
| Pubmed | RGPD4 FLNB RANBP2 CENPC RGPD1 DHX57 CCT4 CLPX LCP1 PRX HP1BP3 KHSRP ABCB4 MEN1 PHEX ABCB9 SACS PRRC2C AHNAK CSPG4 DLG3 ABCC2 MRPL11 HSPA5 PICK1 | 4.05e-08 | 1442 | 170 | 25 | 35575683 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 GRIPAP1 DRG2 IFFO1 GPATCH1 RGPD1 CCT4 ATG2A OSGEP LCP1 PDLIM5 KIF7 MEN1 ACTR1B ACTR1A DPH5 DYNC2LI1 TANC1 PCCB | 4.46e-08 | 853 | 170 | 19 | 28718761 |
| Pubmed | 6.48e-08 | 22 | 170 | 5 | 27717094 | ||
| Pubmed | 6.81e-08 | 9 | 170 | 4 | 9733766 | ||
| Pubmed | The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. | 1.15e-07 | 3 | 170 | 3 | 12628490 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 18799096 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 21940993 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 17494643 | ||
| Pubmed | RGPD4 NES SESTD1 RANBP2 SLC4A8 DRG2 RGPD1 CCT4 MAPK8IP3 KHSRP KIF7 ACTR1A USP10 KIF3B PRRC2C DLG3 HOMER3 RASAL2 TP53BP1 | 2.89e-07 | 963 | 170 | 19 | 28671696 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 16946557 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 18038766 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 FLNB RANBP2 RGPD1 ABCC11 CCT4 KHSRP MEN1 ACTR1A PRRC2C AHNAK MRPL11 HSPA5 TP53BP1 VCP | 7.68e-07 | 647 | 170 | 15 | 26618866 |
| Pubmed | FKBP10 PDE3B ATP7A DRG2 CENPC MAP2 FTSJ1 CLPX NFS1 HP1BP3 KIF7 USP10 RPAP1 SACS HINT2 LSM4 TANC1 HSPA5 SNTB2 RASAL2 TP53BP1 VCP RAD21 | 1.08e-06 | 1487 | 170 | 23 | 33957083 | |
| Pubmed | Mosaic development of the olfactory cortex with Pax6-dependent and -independent components. | 2.27e-06 | 6 | 170 | 3 | 12036513 | |
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 12951053 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.96e-06 | 7 | 170 | 3 | 11353387 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 30944974 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.96e-06 | 7 | 170 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.96e-06 | 7 | 170 | 3 | 17372272 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 38657106 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 21205196 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 18949001 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 25187515 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 8603673 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 26632511 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 24403063 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 23818861 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 23536549 | ||
| Pubmed | Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. | 3.96e-06 | 7 | 170 | 3 | 20922799 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 12191015 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 22821000 | ||
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 20682751 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RANBP2 THSD7A DHX57 ITIH3 KHSRP USP10 DDX46 PRRC2C HOMER3 TP53BP1 VCP RAD21 | 4.28e-06 | 475 | 170 | 12 | 31040226 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.19e-06 | 256 | 170 | 9 | 33397691 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 6.31e-06 | 8 | 170 | 3 | 21670213 | |
| Pubmed | 6.31e-06 | 8 | 170 | 3 | 27412403 | ||
| Pubmed | 6.31e-06 | 8 | 170 | 3 | 15802388 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 6.31e-06 | 8 | 170 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 6.31e-06 | 8 | 170 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 6.31e-06 | 8 | 170 | 3 | 28745977 | |
| Pubmed | NES FLNB MAP2 DHX57 CCT4 SHROOM2 PDLIM5 HP1BP3 MAPK8IP3 KHSRP ACTR1A USP10 SACS PRRC2C LSM4 DLG3 TANC1 HSPA5 HOMER3 RASAL2 VCP | 7.40e-06 | 1431 | 170 | 21 | 37142655 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 9.43e-06 | 9 | 170 | 3 | 18394993 | |
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 28100513 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 17887960 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 11553612 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 10601307 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 28877029 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FKBP10 NES FLNB RANBP2 GRIPAP1 CCT4 IDE CLPX HP1BP3 KHSRP ACTR1A DDX46 NUDT1 AHNAK TSPYL5 HSPA5 TP53BP1 VCP AHNAK2 RAD21 | 1.30e-05 | 1367 | 170 | 20 | 32687490 |
| Pubmed | RGPD4 FLNB RANBP2 GRIPAP1 SLC4A8 MAP2 RGPD1 CCT4 NFS1 SHROOM2 MAPK8IP3 KHSRP PRRC2C TMCC2 DLG3 PCCB TP53BP1 VCP | 1.31e-05 | 1139 | 170 | 18 | 36417873 | |
| Pubmed | 1.34e-05 | 10 | 170 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.34e-05 | 10 | 170 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.34e-05 | 10 | 170 | 3 | 8857542 | |
| Pubmed | Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. | 1.34e-05 | 10 | 170 | 3 | 21282641 | |
| Pubmed | 1.34e-05 | 10 | 170 | 3 | 21859863 | ||
| Pubmed | ABCC3 ZNF142 RIPPLY3 RGPD1 IDE CSMD2 KIF7 HERC6 MAP2K2 HOMER3 SNTB2 RASAL2 AHNAK2 | 1.69e-05 | 638 | 170 | 13 | 31182584 | |
| Pubmed | 1.71e-05 | 65 | 170 | 5 | 34645483 | ||
| Pubmed | 1.84e-05 | 11 | 170 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.84e-05 | 11 | 170 | 3 | 35771867 | |
| Pubmed | 1.84e-05 | 11 | 170 | 3 | 34110283 | ||
| Pubmed | RGPD4 NES HSPG2 FLNB RANBP2 ZNF142 FN3KRP RGPD1 CCT4 CLPX KHSRP AHNAK HDAC10 HSPA5 VCP | 1.88e-05 | 844 | 170 | 15 | 25963833 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB RANBP2 FN3KRP CCT4 GPATCH4 CLPX GTPBP10 HP1BP3 KHSRP USP10 DDX46 PRRC2C AHNAK LSM4 HDAC10 MRPL11 HSPA5 VCP AHNAK2 RAD21 | 2.12e-05 | 1415 | 170 | 20 | 28515276 |
| Pubmed | NES FLNB RANBP2 DHX57 LCP1 HP1BP3 KHSRP DDX46 PRRC2C AHNAK TP53BP1 VCP RAD21 | 2.16e-05 | 653 | 170 | 13 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES PDE3B DRG2 SASH1 MAP2 MAP3K14 SPATA18 ALPK1 CDR2L PRRC2C AHNAK TANC1 MAP2K2 RASAL2 AHNAK2 | 2.36e-05 | 861 | 170 | 15 | 36931259 |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 33961796 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15456787 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25060527 | ||
| Pubmed | p53 regulates ERK1/2/CREB cascade via a novel SASH1/MAP2K2 crosstalk to induce hyperpigmentation. | 2.38e-05 | 2 | 170 | 2 | 28382689 | |
| Pubmed | Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. | 2.38e-05 | 2 | 170 | 2 | 11266082 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29464551 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 7696711 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22210628 | ||
| Pubmed | Skeletal muscle neural progenitor cells exhibit properties of NG2-glia. | 2.38e-05 | 2 | 170 | 2 | 22999866 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15007166 | ||
| Pubmed | Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes. | 2.38e-05 | 2 | 170 | 2 | 3110774 | |
| Pubmed | Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models. | 2.38e-05 | 2 | 170 | 2 | 21841039 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29462330 | ||
| Pubmed | Expression and localization of Na-driven Cl-HCO(3)(-) exchanger (SLC4A8) in rodent CNS. | 2.38e-05 | 2 | 170 | 2 | 18359573 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22899102 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19356220 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22985576 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22914987 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29976647 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12704183 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22671039 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25788542 | ||
| Pubmed | Prolactin increases expression of cytoskeletal proteins in SK-N-SH cells. | 2.38e-05 | 2 | 170 | 2 | 25629269 | |
| Pubmed | Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. | 2.38e-05 | 2 | 170 | 2 | 11745434 | |
| Pubmed | MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. | 2.38e-05 | 2 | 170 | 2 | 22768148 | |
| Pubmed | Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. | 2.38e-05 | 2 | 170 | 2 | 15376331 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 30959153 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20833135 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16508779 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19088030 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12890151 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10952971 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17606722 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 FLNB RANBP2 DRG2 RGPD1 CCT4 HP1BP3 KHSRP ACTR1B ACTR1A DDX46 PRRC2C MAP2K2 | 2.60e-05 | 665 | 170 | 13 | 30457570 |
| Interaction | TOP3B interactions | ABCC3 HSPG2 KHNYN DHX57 GBX2 ATG2A CLPX ZZEF1 SBNO2 CABLES1 MAPK8IP3 CDR2L ACTR1B ACTR1A USP10 SLC38A10 RPAP1 ZNF827 PIK3CD AHNAK TMCC2 CSPG4 LSM4 TANC1 LTK MRPL11 ANKRD33B HSPA5 TP53BP1 PICK1 AHNAK2 | 1.42e-06 | 1470 | 168 | 31 | int:TOP3B |
| GeneFamily | ATP binding cassette subfamily C | 9.56e-07 | 13 | 112 | 4 | 807 | |
| GeneFamily | PDZ domain containing | 4.71e-06 | 152 | 112 | 8 | 1220 | |
| GeneFamily | Collagens | 1.86e-04 | 46 | 112 | 4 | 490 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 7.83e-04 | 7 | 112 | 2 | 570 | |
| GeneFamily | ATP binding cassette subfamily B | 2.02e-03 | 11 | 112 | 2 | 806 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | NES HSPG2 FLNB THSD7A SASH1 ASAH2 RIPPLY3 LCP1 SHROOM2 PDLIM5 CABLES1 NRP1 FZD6 SACS PITPNA ENG RASAL2 | 6.08e-07 | 523 | 163 | 17 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | LGMN HSPG2 FLNB THSD7A SASH1 ASAH2 RIPPLY3 LCP1 SHROOM2 PDLIM5 CABLES1 NRP1 FZD6 SACS PITPNA ENG RASAL2 | 1.97e-06 | 570 | 163 | 17 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | LGMN NES HSPG2 FLNB THSD7A SASH1 ASAH2 RIPPLY3 COL6A5 LCP1 SHROOM2 PDLIM5 CABLES1 NRP1 FZD6 SACS PITPNA MMP15 ENG RASAL2 | 6.18e-06 | 831 | 163 | 20 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | NES HSPG2 FLNB THSD7A SASH1 RNF19A ASAH2 RIPPLY3 LCP1 SHROOM2 PDLIM5 CABLES1 NRP1 FZD6 SACS PITPNA MMP15 ENG RASAL2 | 2.84e-05 | 847 | 163 | 19 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 | HSPG2 MDFIC THSD7A SASH1 RNF19A IFFO1 ASAH2 RIPPLY3 ALPK1 PDLIM5 SBNO2 CDR2L TMCC2 PITPNA HINT2 FAM3C HDAC10 RASAL2 ACSL5 | 2.98e-05 | 850 | 163 | 19 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 1.06e-04 | 298 | 163 | 10 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.08e-08 | 181 | 168 | 9 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.90e-08 | 186 | 168 | 9 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.90e-08 | 186 | 168 | 9 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 4.48e-08 | 189 | 168 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.68e-08 | 190 | 168 | 9 | 52213cd2a6a20772d4f49ba9ac0407abafa528db | |
| ToppCell | P03-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.68e-08 | 190 | 168 | 9 | 347c7bf67ade235a4e2320db6a75ce0dab8744f9 | |
| ToppCell | P03-Endothelial-unknown_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.68e-08 | 190 | 168 | 9 | 0c7da05fbd3f095dde7550585209c056f0b76990 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-08 | 192 | 168 | 9 | ff435141329e3e29fa9b08a4d5b2f55074e7f9ab | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-08 | 193 | 168 | 9 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.93e-07 | 171 | 168 | 8 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.93e-07 | 171 | 168 | 8 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.91e-07 | 183 | 168 | 8 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.91e-07 | 183 | 168 | 8 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.55e-07 | 186 | 168 | 8 | a38f84f478798951c8798c8e90e4897c729cf630 | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.55e-07 | 186 | 168 | 8 | dde38decf368775694bbeae38a3ff084017c34ab | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.78e-07 | 187 | 168 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.26e-07 | 189 | 168 | 8 | fcfb28bd96471affc13e55aa7228f594aaa967cd | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-07 | 189 | 168 | 8 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.26e-07 | 189 | 168 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.26e-07 | 189 | 168 | 8 | f515a04ae1746257d4568cea13a3dd75b4b05275 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 190 | 168 | 8 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-07 | 191 | 168 | 8 | 38fe60a8570f3c6eb8e8f8646f90d505dfd7d647 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-07 | 191 | 168 | 8 | 0e6cd2628a5cebd35e960e4eb3b52ddc9358031c | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-07 | 191 | 168 | 8 | 40e617d3c93f03ae87baf6c0b2304b617f5fe782 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-07 | 192 | 168 | 8 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-07 | 193 | 168 | 8 | ffdcbc5caff7fd4cc2e83dd21a05d43b0593d542 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-07 | 193 | 168 | 8 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-07 | 193 | 168 | 8 | 4893b922e129711d5886bd4f3ee106e9e7065971 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-07 | 194 | 168 | 8 | cf7f232827945fbafd2c298c08a799ab916c2472 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-07 | 194 | 168 | 8 | e13923860a64ba9cf32df53c9f0cf4e7c321881d | |
| ToppCell | droplet-Lung-21m-Endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-07 | 194 | 168 | 8 | b45aebbc7641df0bf56d0c2e88821f1daf705449 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 7.63e-07 | 194 | 168 | 8 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | droplet-Lung-1m-Endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-07 | 194 | 168 | 8 | b1a25e3b36e7b7e558ef95ec22a3bdcbceae821f | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-07 | 194 | 168 | 8 | 68efc6df31479839a3bd5fe9fbc98ddceecc3b10 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-07 | 194 | 168 | 8 | 03985e4ab10f140f758e70dc7bfaa059b4e3bb18 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.63e-07 | 194 | 168 | 8 | 86508dd9b9d345b6624d185048cc92b81dd11c2a | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 1621ce2968f3100e4c39e0ef8293232a5d76c614 | |
| ToppCell | severe_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 2.47e-06 | 159 | 168 | 7 | e1c48c4ceda116826819ff9adeed7bad6a58844d | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.47e-06 | 159 | 168 | 7 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.58e-06 | 160 | 168 | 7 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.58e-06 | 160 | 168 | 7 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 4.16e-06 | 172 | 168 | 7 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 175 | 168 | 7 | 98dc3b6f69a29d587f503898f09912700950e3d9 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 5.21e-06 | 178 | 168 | 7 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 178 | 168 | 7 | 1a578d16008a450c42e73a996247ffecdc2c43f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.40e-06 | 179 | 168 | 7 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.40e-06 | 179 | 168 | 7 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 181 | 168 | 7 | 859c40889ede2cbf374c4d2efbb72dc3bc6441f5 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 181 | 168 | 7 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 6.03e-06 | 182 | 168 | 7 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | P28-Endothelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.47e-06 | 184 | 168 | 7 | b056411f499866097f4322999cfd1e57a3927b78 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 6.71e-06 | 185 | 168 | 7 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.95e-06 | 186 | 168 | 7 | 26a625ca0300055d6af3472aa0bfba59b73db292 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.95e-06 | 186 | 168 | 7 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.95e-06 | 186 | 168 | 7 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.95e-06 | 186 | 168 | 7 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.95e-06 | 186 | 168 | 7 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.95e-06 | 186 | 168 | 7 | 375642f353842184792a834361284d6897c728de | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.95e-06 | 186 | 168 | 7 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.95e-06 | 186 | 168 | 7 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.95e-06 | 186 | 168 | 7 | 72aab20b848dd9e1101a4bc2466e08aed5f8bbb6 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 6.95e-06 | 186 | 168 | 7 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 7.20e-06 | 187 | 168 | 7 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | P03-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.20e-06 | 187 | 168 | 7 | 55618ceec367c1c51ed5c447063d7fbd5c7e0808 | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.45e-06 | 188 | 168 | 7 | db0652f000d459493321b53239326706eace598c | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.45e-06 | 188 | 168 | 7 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 188 | 168 | 7 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.45e-06 | 188 | 168 | 7 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 188 | 168 | 7 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 7.45e-06 | 188 | 168 | 7 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | COVID-19_Severe-pDC|World / disease group, cell group and cell class | 7.45e-06 | 188 | 168 | 7 | 4c8e328b8206120708b05ea3c5865a0200dc5c4e | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.45e-06 | 188 | 168 | 7 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 188 | 168 | 7 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 7.45e-06 | 188 | 168 | 7 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.71e-06 | 189 | 168 | 7 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.71e-06 | 189 | 168 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.71e-06 | 189 | 168 | 7 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.71e-06 | 189 | 168 | 7 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 7.71e-06 | 189 | 168 | 7 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 7.71e-06 | 189 | 168 | 7 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.71e-06 | 189 | 168 | 7 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.71e-06 | 189 | 168 | 7 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.98e-06 | 190 | 168 | 7 | adffa93635da10251f28b2089fd96b189775c8b4 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.98e-06 | 190 | 168 | 7 | 9a91bf1ea105029e6412d0d9060bca325299ce26 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.98e-06 | 190 | 168 | 7 | 39c8ddc2639bf3e986dae11fbae61a735614b604 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.98e-06 | 190 | 168 | 7 | 2c1c079fd411c03bc3f383aa927eea9446716960 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.98e-06 | 190 | 168 | 7 | a95aea3aa707fc4574810706341a5f32b3d00209 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.98e-06 | 190 | 168 | 7 | 18dfa84c62dcf081ce9958a71e76a394ec0968e4 | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 7.98e-06 | 190 | 168 | 7 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 8.26e-06 | 191 | 168 | 7 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 8.26e-06 | 191 | 168 | 7 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 8.26e-06 | 191 | 168 | 7 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.26e-06 | 191 | 168 | 7 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.26e-06 | 191 | 168 | 7 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.26e-06 | 191 | 168 | 7 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 8.26e-06 | 191 | 168 | 7 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | Healthy-pDC|World / disease group, cell group and cell class | 8.26e-06 | 191 | 168 | 7 | 6e1d825dc33b915b95f13ccd237a552160a4be98 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.26e-06 | 191 | 168 | 7 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 192 | 168 | 7 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 192 | 168 | 7 | 35f7926628a967f85b26371e795a1b93c6f103ab | |
| Drug | nicotine glucuronide | 1.91e-07 | 8 | 167 | 4 | CID003035848 | |
| Drug | 5-carboxyfluorescein diacetate | 3.88e-07 | 3 | 167 | 3 | ctd:C084577 | |
| Drug | PAK-104P | 3.58e-06 | 15 | 167 | 4 | CID000131368 | |
| Drug | d-dm | 7.21e-06 | 37 | 167 | 5 | CID000007576 | |
| Drug | AC1NB6SN | 7.63e-06 | 6 | 167 | 3 | CID004488324 | |
| Drug | coproporphyrin I | 7.89e-06 | 18 | 167 | 4 | CID000068271 | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HG-U133A | 1.50e-05 | 196 | 167 | 9 | 492_DN | |
| Drug | estradiol-17 beta-glucuronide | 1.84e-05 | 22 | 167 | 4 | ctd:C025483 | |
| Drug | AC1LD8HW | 1.89e-05 | 75 | 167 | 6 | CID000644061 | |
| Drug | calcein AM | 2.11e-05 | 8 | 167 | 3 | ctd:C085925 | |
| Drug | T beta-MC | 2.11e-05 | 8 | 167 | 3 | CID000168408 | |
| Drug | probenecid | 3.50e-05 | 123 | 167 | 7 | CID000004911 | |
| Drug | zearalenol | 4.30e-05 | 27 | 167 | 4 | ctd:C029659 | |
| Drug | Pyrazinamide | 4.30e-05 | 27 | 167 | 4 | ctd:D011718 | |
| Drug | AC1NN9F1 | 4.48e-05 | 10 | 167 | 3 | CID000000410 | |
| Drug | CID5288653 | 4.98e-05 | 28 | 167 | 4 | CID005288653 | |
| Drug | 5(6)-carboxy-2',7'-dichlorofluorescein | 5.35e-05 | 2 | 167 | 2 | ctd:C053897 | |
| Drug | Sulfinpyrazone | 5.35e-05 | 2 | 167 | 2 | DB01138 | |
| Drug | glutathione-BPDE conjugate | 5.35e-05 | 2 | 167 | 2 | ctd:C113118 | |
| Drug | robinetin | 5.35e-05 | 2 | 167 | 2 | ctd:C040014 | |
| Drug | Fluo-3 | 5.35e-05 | 2 | 167 | 2 | ctd:C059715 | |
| Drug | E3040 glucuronide | 5.35e-05 | 2 | 167 | 2 | CID000443294 | |
| Drug | isoquercitrin | 5.75e-05 | 29 | 167 | 4 | CID005280804 | |
| Drug | physcione | 6.12e-05 | 11 | 167 | 3 | ctd:C008905 | |
| Drug | AC1L9E0Q | 6.59e-05 | 30 | 167 | 4 | CID000443095 | |
| Drug | AC1L1HS4 | 8.55e-05 | 32 | 167 | 4 | CID000004267 | |
| Drug | AC1L2DAI | ABCC3 ABCC1 HSPG2 ACTRT3 HMBS CLPX ACTR1B ACTR1A ABCC2 HSPA5 | 8.68e-05 | 304 | 167 | 10 | CID000004984 |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 9.26e-05 | 193 | 167 | 8 | 6846_UP | |
| Drug | trimethylarsine oxide | 9.68e-05 | 33 | 167 | 4 | ctd:C052920 | |
| Drug | oryzalin | 9.97e-05 | 63 | 167 | 5 | CID000029393 | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A | 1.03e-04 | 196 | 167 | 8 | 1982_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 5540_DN | |
| Drug | propachlor | 1.05e-04 | 13 | 167 | 3 | CID000004931 | |
| Drug | harmol sulfate | 1.05e-04 | 13 | 167 | 3 | CID005488302 | |
| Drug | adefovir | 1.07e-04 | 64 | 167 | 5 | CID000060172 | |
| Drug | tenofovir disoproxil fumarate | 1.09e-04 | 34 | 167 | 4 | CID005481350 | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 4798_DN | |
| Drug | Y-27632; Down 200; 3uM; MCF7; HT_HG-U133A_EA | 1.11e-04 | 198 | 167 | 8 | 948_DN | |
| Drug | Racecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 6231_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 3415_UP | |
| Drug | iloprost; Down 200; 1uM; MCF7; HG-U133A | 1.14e-04 | 199 | 167 | 8 | 488_DN | |
| Drug | methenamine silver | 1.23e-04 | 201 | 167 | 8 | CID000004101 | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 5.70e-06 | 7 | 163 | 3 | DOID:2741 (biomarker_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 1.57e-04 | 49 | 163 | 4 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Bipolar Disorder | THSD7A MAP2 HLA-DRB4 PHETA1 DDC PDLIM5 ITIH3 DLG3 DLX1 HSPA5 | 3.39e-04 | 477 | 163 | 10 | C0005586 |
| Disease | phospholipids in large VLDL measurement | 3.90e-04 | 62 | 163 | 4 | EFO_0022169 | |
| Disease | cholesterol in large VLDL measurement | 4.67e-04 | 65 | 163 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.67e-04 | 65 | 163 | 4 | EFO_0022230 | |
| Disease | total lipids in large VLDL | 5.25e-04 | 67 | 163 | 4 | EFO_0022175 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 5.25e-04 | 67 | 163 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | Colorectal Carcinoma | ABCC3 ABCC1 MAP2 PHETA1 CABLES1 ABCB4 RPAP1 SACS DLG3 ABCC2 RASAL2 ACSL5 | 5.55e-04 | 702 | 163 | 12 | C0009402 |
| Disease | free cholesterol in large VLDL measurement | 5.55e-04 | 68 | 163 | 4 | EFO_0022265 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 7.99e-04 | 33 | 163 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Cholestasis of pregnancy | 8.31e-04 | 8 | 163 | 2 | C0268318 | |
| Disease | Todd Paralysis | 1.06e-03 | 9 | 163 | 2 | C0234544 | |
| Disease | Paralysed | 1.06e-03 | 9 | 163 | 2 | C0522224 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 1.06e-03 | 9 | 163 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 1.06e-03 | 9 | 163 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | HSPG2 SLC4A8 GPATCH1 LCP1 ITIH3 SBNO2 HP1BP3 PHEX ACTR1A ZNF827 ASGR1 AHNAK PCCB TP53BP1 | 1.56e-03 | 1015 | 163 | 14 | EFO_0004533 |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 1.61e-03 | 11 | 163 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | Tremor | 1.61e-03 | 11 | 163 | 2 | C0040822 | |
| Disease | triglycerides in large LDL measurement | 1.74e-03 | 43 | 163 | 3 | EFO_0022319 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.77e-03 | 229 | 163 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.93e-03 | 12 | 163 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | rotator cuff tear | 1.93e-03 | 12 | 163 | 2 | EFO_1001250 | |
| Disease | Heart Diseases | 2.11e-03 | 46 | 163 | 3 | C0018799 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.27e-03 | 13 | 163 | 2 | C3501611 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0800474 | |
| Disease | X-24588 measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0800898 | |
| Disease | neuroimaging measurement | MAP2 RGPD1 COL22A1 HP1BP3 MAPK8IP3 NRP1 ACTR1B ACTR1A COL24A1 NALF1 PRRC2C FAM3C SNTB2 PICK1 | 2.52e-03 | 1069 | 163 | 14 | EFO_0004346 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.53e-03 | 49 | 163 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.68e-03 | 50 | 163 | 3 | EFO_0022334 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.68e-03 | 50 | 163 | 3 | EFO_0022247 | |
| Disease | Tourette syndrome | 2.68e-03 | 50 | 163 | 3 | EFO_0004895 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.84e-03 | 51 | 163 | 3 | EFO_0022331 | |
| Disease | phospholipids in very small VLDL measurement | 2.84e-03 | 51 | 163 | 3 | EFO_0022300 | |
| Disease | eosinophil percentage of leukocytes | GRIPAP1 ACTRT3 HLA-DRB3 LCP1 SBNO2 CABLES1 PIK3CD SHARPIN LSM4 MAP2K2 ANKRD33B | 2.99e-03 | 746 | 163 | 11 | EFO_0007991 |
| Disease | triglycerides in HDL measurement | 3.17e-03 | 53 | 163 | 3 | EFO_0022317 | |
| Disease | total lipids in medium VLDL | 3.34e-03 | 54 | 163 | 3 | EFO_0022153 | |
| Disease | sexual dimorphism measurement | ZNF142 RIPK3 SPATA18 RGPD1 NFS1 LCP1 ZZEF1 GSDMC CABLES1 KLHL29 ACTR1A FER1L4 ALPK3 TP53BP1 | 3.41e-03 | 1106 | 163 | 14 | EFO_0021796 |
| Disease | focal segmental glomerulosclerosis | 3.46e-03 | 16 | 163 | 2 | EFO_0004236 | |
| Disease | triglycerides in medium VLDL measurement | 3.52e-03 | 55 | 163 | 3 | EFO_0022155 | |
| Disease | triglycerides in very large HDL measurement | 3.52e-03 | 55 | 163 | 3 | EFO_0022324 | |
| Disease | ecosanoids measurement | 3.52e-03 | 55 | 163 | 3 | EFO_0020044 | |
| Disease | triglycerides in large VLDL measurement | 3.70e-03 | 56 | 163 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 3.70e-03 | 56 | 163 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 3.70e-03 | 56 | 163 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.70e-03 | 56 | 163 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 3.70e-03 | 56 | 163 | 3 | EFO_0022251 | |
| Disease | cancer (implicated_via_orthology) | 3.85e-03 | 268 | 163 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 3.91e-03 | 17 | 163 | 2 | C1839839 | |
| Disease | X-21441 measurement | 3.91e-03 | 17 | 163 | 2 | EFO_0800814 | |
| Disease | metabolite measurement | 4.07e-03 | 560 | 163 | 9 | EFO_0004725 | |
| Disease | triglycerides in IDL measurement | 4.09e-03 | 58 | 163 | 3 | EFO_0022149 | |
| Disease | response to carboplatin | 4.09e-03 | 58 | 163 | 3 | GO_0097328 | |
| Disease | triglycerides in VLDL measurement | 4.29e-03 | 59 | 163 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 4.29e-03 | 59 | 163 | 3 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 4.29e-03 | 59 | 163 | 3 | EFO_0022301 | |
| Disease | triglycerides to total lipids in large HDL percentage | 4.50e-03 | 60 | 163 | 3 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 4.50e-03 | 60 | 163 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.50e-03 | 60 | 163 | 3 | EFO_0022233 | |
| Disease | Colorectal Neoplasms | 4.51e-03 | 277 | 163 | 6 | C0009404 | |
| Disease | triglycerides in small VLDL measurement | 4.71e-03 | 61 | 163 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 4.71e-03 | 61 | 163 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 4.71e-03 | 61 | 163 | 3 | EFO_0022276 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.71e-03 | 61 | 163 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.88e-03 | 19 | 163 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | triglycerides in small HDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022158 | |
| Disease | triglycerides in medium LDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022322 | |
| Disease | total lipids in very large VLDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022299 | |
| Disease | triglycerides to total lipids in IDL percentage | 5.16e-03 | 63 | 163 | 3 | EFO_0022329 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 5.16e-03 | 63 | 163 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 5.16e-03 | 63 | 163 | 3 | EFO_0022292 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQVKGLSTQGGNVGR | 86 | P07306 | |
| VQEIVGALRKGGGDR | 21 | Q969T7 | |
| IGGGILSQDRVIDGQ | 391 | Q5FYA8 | |
| VKGGQRNITDDSRGQ | 251 | Q9Y6F7 | |
| LRGGEEGQGEVKAGE | 401 | Q86X02 | |
| GGKVQEGETIEDGAR | 36 | P36639 | |
| TVGDGGQDGDQKTVL | 461 | Q7Z408 | |
| ALQFGELQKQGAGGV | 706 | Q6UVK1 | |
| DDTGRGIIKGSINAQ | 1126 | Q96M83 | |
| GGEGVQQGLLKLLEG | 376 | O76031 | |
| GRAKGQSRAAQGGLE | 36 | Q9BYD9 | |
| ITYGKGQGQGESLRV | 186 | Q9BYG8 | |
| GRAAGIAVNENGKGL | 576 | Q9UK96 | |
| GVVVGDEGKGLIEGN | 626 | Q9UK96 | |
| NGSGVIKAGFAGDQI | 16 | P42025 | |
| GKIQVDGRTRGDGTQ | 816 | Q96L96 | |
| SGVNVNAKGLDLGGR | 256 | Q09666 | |
| NAKGLDLGGRGGVQV | 261 | Q09666 | |
| STVVEGGEVRFNGKG | 111 | P56177 | |
| AFLNEKAGEGGGVIQ | 131 | P20711 | |
| GGTVELIQGRAAKGN | 501 | P17813 | |
| EGVTERGASGRKGQG | 1026 | Q2TAZ0 | |
| QGKEQGEEISERGAG | 761 | Q96QP1 | |
| EVGGAGQRGRTGQED | 361 | A6NCL7 | |
| TGVGAQNGILIKGGE | 1016 | Q04656 | |
| RGQLEQITGKGASGT | 311 | Q5SSJ5 | |
| SELGAGNGGVVTKVQ | 76 | P36507 | |
| DGSQVKRTGGAEDGA | 266 | A6NED2 | |
| DISGQKNGRGVIFGQ | 1926 | P49792 | |
| QGAGEEIGKTAAFRN | 776 | Q9Y5E4 | |
| QGVEVGEAGQGKDFI | 4246 | P98160 | |
| GEAGQGKDFISLGLQ | 4251 | P98160 | |
| SEEGKQEGRGGQDLS | 676 | Q7Z6P3 | |
| GGILDDKLISNNDGG | 226 | O60216 | |
| KGAVLAQGQGDGTVS | 526 | P48382 | |
| VAEASKNETGGGEGV | 26 | Q00169 | |
| KNETGGGEGVEVLVN | 31 | Q00169 | |
| QTEIGEKGINLSGGQ | 741 | O15438 | |
| KGNEDRRGQTVNAGV | 206 | O00255 | |
| GLARVGADDQKIAAG | 221 | Q9H2P9 | |
| QGLASGEKVAGLQGL | 126 | Q8WTU0 | |
| GRGINVALANGKTGE | 101 | Q92520 | |
| GGRGKQDIGDILQQI | 46 | P40425 | |
| GQVRGAAGVTDGNEV | 26 | Q9BX68 | |
| KGVLQITGLRAEDGG | 191 | Q8IVU1 | |
| GQKLRNVLVLSGGEG | 1276 | Q9UPT6 | |
| QQYGRGKSGGQVRDE | 121 | A6PVI3 | |
| VRVEALQSGGGQERG | 276 | Q9Y697 | |
| GVGTGNGTRLVVEKE | 116 | O14931 | |
| QRVAEAGGGQLGSTA | 16 | Q9P1T7 | |
| RLKEAGTVGRGGGQE | 121 | Q9HA64 | |
| GILTAAAQEGGRNDG | 56 | Q8TC71 | |
| AAQEGGRNDGVETIK | 61 | Q8TC71 | |
| IDGVGGLNFTQGKTE | 461 | Q9NR71 | |
| GLENLTIKGGRQSGA | 1896 | Q2LD37 | |
| FGAGVNKDGGSRVVV | 601 | P51511 | |
| RDSLQGLNEGVGQGI | 321 | A9Z1Z3 | |
| KRGINGSEGDGAEIA | 16 | Q8TCX1 | |
| GEKEGLGQGQSLEQL | 246 | Q9NSC5 | |
| GRTNQEVLDFVVGGG | 726 | P29376 | |
| GAEGVVENGGIINKI | 196 | Q14232 | |
| GSERAGDLGEIGLNK | 261 | Q9BRR8 | |
| QGKGLGRKENGITQA | 26 | Q5T3I0 | |
| VDTRGAGGQGKLDVT | 966 | O75369 | |
| VGIGGQDLNEGNRTL | 476 | P13796 | |
| GGGNGVDLSVLNEAR | 346 | Q13370 | |
| AGSEGQLGIGEFKEI | 101 | Q8IVU3 | |
| EIGERGLNLSGGQKQ | 626 | Q96J66 | |
| KGRDQGINQGQRSSG | 151 | P57055 | |
| GAGGRKEDEGAQQLL | 476 | Q2M1P5 | |
| GQAQIRKVDQGGLGA | 866 | Q9UJF2 | |
| EQRGLVEGASVKGGA | 1021 | P48681 | |
| VEGASVKGGAEGLQD | 1026 | P48681 | |
| LAEIGEKGINLSGGQ | 751 | Q92887 | |
| GGKAAQANVRIGDVV | 36 | Q96HC4 | |
| GFEGSANKIGVGVVR | 6 | Q9NPF4 | |
| GQRSGTEVGRAGKGQ | 116 | Q9UBG3 | |
| VGERGAQLSGGQKQR | 526 | P21439 | |
| GDKGTQLSGGQKQRI | 1176 | P21439 | |
| QQALEEGKQGRRGLG | 106 | Q0D2I5 | |
| IGLNDSGGARIQEGV | 156 | P05166 | |
| GKGNLGGIAVDDISI | 786 | O14786 | |
| SRLSGEQVDGKGQAG | 626 | O60353 | |
| FRNGQEEKAGVVSTG | 161 | P79483 | |
| DGRGQTGQEKGRAEG | 171 | Q8N8I6 | |
| QASLVGAVRGQGKDE | 171 | P52951 | |
| GANKVIEGLDTGLQG | 431 | Q96AY3 | |
| ADAVGRGQGLGFTVN | 211 | Q969S8 | |
| KENDRILVAQGGLGG | 111 | A4D1E9 | |
| QVGDLKLDGGRQSTG | 361 | Q8TDN4 | |
| RSGLQQGKGNVDGVA | 6 | Q9H2C2 | |
| VQKFLNAEGSGGIVG | 591 | Q03188 | |
| EKRAQGGDGVLDATG | 1186 | Q6P158 | |
| GEQGRQGRSGQKGVQ | 1531 | A8TX70 | |
| VNVGSIVGLKGNSGQ | 131 | Q8N4T8 | |
| NGSGVIKAGFAGDQI | 16 | P61163 | |
| NQSVGIEGGARKGVS | 46 | Q9ULC5 | |
| GERGADGEVGQKGDQ | 1171 | Q8NFW1 | |
| IEGGAAQKDGRLQIG | 261 | Q92796 | |
| FRNGQEEKAGVVSTG | 161 | P13762 | |
| GEQGVKGEKGERGEN | 406 | Q9UEW3 | |
| EEVVAKGRGRGGLQQ | 81 | Q9Y4Z0 | |
| QQQGREEEKGSGGIR | 616 | O15037 | |
| GGRNRNGQIEDISKG | 331 | Q86TM3 | |
| VNTLVGGQKEGARGF | 356 | P14735 | |
| GQGALGVEVRAKDQD | 216 | P08397 | |
| GGTGISEQIAELKRG | 481 | Q7L014 | |
| GSLQQRDGAKAEVGD | 406 | Q96DZ5 | |
| QLKEGAAGAGVAQAG | 116 | Q4V328 | |
| NGILRVTAEDKGTGN | 506 | P11021 | |
| LGEVEERGTGNKAGV | 1316 | D6RIA3 | |
| GGIGAAVARALVQQG | 21 | Q6UWP2 | |
| QKRSGERQSNGEGIG | 271 | Q8N697 | |
| VRGIQNLGKGTKEGN | 2601 | Q9NZJ4 | |
| LSEQQNGLAVGGGEK | 611 | Q9HBR0 | |
| QKGDDGVRGFVGVIG | 1131 | P25940 | |
| ISGQKNGRGVIFGQT | 936 | P0DJD0 | |
| ELGGKVNRALQQVGG | 646 | Q99558 | |
| GDRTEIGEKGVNLSG | 756 | P33527 | |
| IGEKGVNLSGGQKQR | 761 | P33527 | |
| GIEKGARQTGKEVAG | 96 | Q9Y3B7 | |
| GRGGEQINKIQQDSG | 161 | Q92945 | |
| GRGGENVKAINQQTG | 441 | Q92945 | |
| GAANVAKGAVQGGLD | 461 | Q96Q06 | |
| DISGQKNGRGVIFGQ | 951 | Q7Z3J3 | |
| GRGQLTFNVEAVGIG | 11 | Q9BT43 | |
| RELEQQLAAVRGGGG | 121 | Q8N4B1 | |
| QQGLKDVGANVRAGI | 381 | O75069 | |
| VNGEDLGFGGIQVRS | 1431 | Q9UPZ6 | |
| GQQGRTEEKDGGLGN | 241 | Q7RTX9 | |
| GLTVNGQITGDKRGS | 686 | Q06033 | |
| SEGAKNGQESGLEIG | 2036 | Q9Y520 | |
| ADGGRLVEVQLSGGA | 21 | Q13796 | |
| RAIAGGDEKGAAQVA | 181 | Q9H0F6 | |
| ENRGAVVVGNVGFGK | 406 | Q9C0D5 | |
| QGEKTAGINVRKGGI | 486 | P50991 | |
| GVGKGRTVAGVILEN | 281 | Q9Y2G9 | |
| RGKGASQGEEGLEAL | 76 | Q2Y0W8 | |
| EGAAQGKGRGRQVIA | 121 | P55039 | |
| NAVGEGEQRTGTEVK | 56 | Q8NCY6 | |
| GSGNQKVGAIVNTIG | 401 | Q96FL8 | |
| SVDVGLQGLREKGQG | 426 | Q86VW0 | |
| GVQAGSQLVGQRKGG | 796 | P0C7V6 | |
| TGEKGAQLSGGQKQR | 636 | Q9NP78 | |
| DRGGAGKLEVAQTQA | 5206 | Q8IVF2 | |
| EVGDQGNIGKIGETG | 841 | Q17RW2 | |
| GEQGIQGAKGEKGDQ | 936 | Q17RW2 | |
| QGEQGLKGERGSEGN | 1251 | Q17RW2 | |
| GGIGASEVKLNGQEV | 781 | O75443 | |
| DRGTIVAQGGGKALI | 666 | Q8IWX7 | |
| GSGRAEKNGDIGGQI | 76 | Q96PE6 | |
| GGAQFEGEKGRALQI | 506 | Q86XI8 | |
| GVSAGNGKGVRIEFD | 461 | Q9NV58 | |
| LENQELVGKGGFGTV | 21 | Q9Y572 | |
| GDGGGAADRVINQIL | 591 | P55072 | |
| LAGSERQAKTGAQGE | 246 | O15066 | |
| LGKGNQVEAEGAGAG | 326 | P23942 | |
| QTGVSGINVAGGGKE | 26 | Q9BXM0 | |
| AGTGEDQVVLPGQGK | 1626 | O15015 | |
| GGSVGIIFKNGDDLR | 771 | O00329 | |
| GKRTLGENIADNGGL | 636 | P78562 | |
| DALKQGQEEGRLGGG | 776 | O94885 | |
| KIRIAAEGINGTVGG | 201 | Q5T7W7 | |
| EEDGDAGLGIRQGGK | 1376 | Q12888 | |
| QLVKKGNRGGGDANS | 31 | Q9BWH6 | |
| AATLGKGTEQRGVGA | 36 | Q6ZWC4 | |
| GGGRAQIGVVDDEAK | 201 | O15195 | |
| IKDQGGAGEGLVRSA | 31 | P11137 | |
| LGQQREGGGTELVGT | 486 | Q17R98 | |
| QKIGGQGSGHVVAVD | 61 | Q9UET6 | |
| QREGNSGGKTIAEAG | 71 | Q9UIE0 | |
| QGAELSEAGNGKRAV | 1996 | O43149 | |
| ENDGVSGGLGQRERK | 136 | Q14694 | |
| KGQGAQRLEGDVVSG | 141 | P52746 | |
| VNKLGAGVDSGRQGS | 6 | P36406 | |
| EGSGLINGQIAKDLG | 646 | Q96PF1 | |
| QEAGGLGISIKGGRE | 121 | Q13425 | |
| QKDAQNLIGISIGGG | 26 | Q9NRD5 | |
| AGDEITGVNGRSIKG | 66 | Q9NRD5 | |
| QVIAGGRQKKGAAGE | 161 | Q86VY4 | |
| GGVNEAGRAAGVLQS | 736 | Q96CT2 | |
| IGGARQGGVNTDKVQ | 446 | Q6PF15 | |
| VLRGDAEAVKGIGSG | 116 | Q99538 | |
| SRGAAGGDGQEVRSK | 196 | B1AL88 |